Alcohol and other substance use during the COVID-19 pandemic: A systematic review

A Roberts, J Rogers, R Mason, AN Siriwardena… - Drug and alcohol …, 2021 - Elsevier
Background Although evidence suggests substance and alcohol use may change during the
Covid-19 pandemic there has been no full review of the evidence around this. Methods A …

Substance use disorder in the COVID-19 pandemic: a systematic review of vulnerabilities and complications

Y Wei, R Shah - Pharmaceuticals, 2020 - mdpi.com
As the world endures the coronavirus disease 2019 (COVID-19) pandemic, the conditions of
35 million vulnerable individuals struggling with substance use disorders (SUDs) worldwide …

Effect of Risk Mitigation Guidance opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort …

A Slaunwhite, JE Min, H Palis, K Urbanoski, B Pauly… - bmj, 2024 - bmj.com
Objective To determine the effect of opioid and stimulant Risk Mitigation Guidance (RMG)
dispensations on mortality and acute care visits during the dual public health emergencies …

'They already operated like it was a crisis, because it always has been a crisis': a qualitative exploration of the response of one homeless service in Scotland to the …

T Parkes, H Carver, W Masterton, D Falzon… - Harm Reduction …, 2021 - Springer
Background The COVID-19 pandemic has necessitated unprecedented changes in the way
that services are delivered to individuals experiencing homelessness and problem …

Evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of COVID-19 and overdose in British Columbia …

B Nosyk, A Slaunwhite, K Urbanoski, N Hongdilokkul… - BMJ open, 2021 - bmjopen.bmj.com
Introduction The COVID-19 pandemic was preceded by an ongoing overdose crisis and
linked to escalating drug overdose deaths in British Columbia (BC). At the outset of these …

Factors associated with 60-day adherence to “safer supply” opioids prescribed under British Columbia's interim clinical guidance for health care providers to support …

M Selfridge, K Card, T Kandler, E Flanagan… - International Journal of …, 2022 - Elsevier
Abstract Aims In March 2020, British Columbia issued Risk Mitigation Guidance (RMG) to
support prescribing of pharmaceutical alternatives to illicit drugs, in order to reduce risk for …

Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada

K Papamihali, M Yoon, B Graham, M Karamouzian… - Harm reduction …, 2020 - Springer
Abstract Background North American communities are severely impacted by the overdose
crisis, particularly in British Columbia (BC), which has the highest toxic drug overdose death …

It's just a perfect storm”: Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use …

A Foreman-Mackey, J Xavier, J Corser, M Fleury… - BMC Public Health, 2023 - Springer
Background Despite the implementation and expansion of public health and harm reduction
strategies aimed at preventing and reversing overdoses, rates of overdose-related events …

The estimated impact of state‐level support for expanded delivery of substance use disorder treatment during the COVID‐19 pandemic

ED Nesoff, ME Marziali, SS Martins - Addiction, 2022 - Wiley Online Library
Abstract Background and Aims To prevent COVID‐19 transmission, some United States
(US) federal regulations on substance use disorder (SUD) treatment were suspended in …

[HTML][HTML] Evidence-informed policy brief-Substance use and related harms in the context of COVID-19: a conceptual model

A Enns, A Pinto, J Venugopal… - Health promotion and …, 2020 - ncbi.nlm.nih.gov
As the effects of COVID-19 have been unfolding, growing attention has been paid to the
intersection of COVID-19 and substance use and the related harms. However, there are few …